Statin therapy enhances the efficacy of HER2 directed antibody-drug conjugates in breast cancer

被引:0
|
作者
Liu, Bo [1 ]
Drago, Joshua Z. [1 ]
Rao, Yi [1 ]
Pereira, Patricia R. [2 ]
Safonov, Anton [1 ]
Marra, Antonio [1 ]
Ahmed, Mehnaj S. [1 ]
Modi, Shanu [1 ]
Reis-Filho, Jorge S. [1 ]
Montemurro, Filippo [3 ]
Razavi, Pedram [1 ]
Lewis, Jason S. [1 ]
Chandarlapaty, Sarat [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Candiolo Canc Inst, Turin, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1787
引用
收藏
页数:2
相关论文
共 50 条
  • [31] A narrative review of human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates in the treatment of breast cancer
    Li, Qun
    Guo, Ye
    Lin, Fengjuan
    Li, Lingjun
    Ge, Xiaoxiao
    Zhao, Wei
    Li, Jin
    TRANSLATIONAL BREAST CANCER RESEARCH, 2021, 2
  • [32] What's next? Antibody-drug conjugates for breast cancer therapy
    Sanz, L.
    Saura, C.
    BREAST, 2023, 68 : S5 - S6
  • [33] Antibody-drug conjugates in breast cancer: Marching from HER2-overexpression into HER2-low
    Fan, Pinchao
    Xu, Kun
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (01):
  • [34] Antibody-Drug Conjugates for Targeted Cancer Therapy
    Goldmacher, Victor S.
    Chittenden, Thomas
    Chari, Ravi V. J.
    Kovtun, Yelena V.
    Lambert, John M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 47, 2012, 47 : 349 - 366
  • [35] ANTIBODY-DRUG CONJUGATES FOR CANCER-THERAPY
    REISFELD, RA
    YANG, HM
    MULLER, B
    WRASIDLO, W
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 86 - MEDI
  • [36] Impact of Maleimide Disubstitution on Chemical and Biological Characteristics of HER2 Antibody-Drug Conjugates
    Feuillatre, Ofelia
    Gely, Camille
    Huvelle, Steve
    Baltus, Christine B.
    Juen, Ludovic
    Joubert, Nicolas
    Desgranges, Audrey
    Viaud-Massuard, Marie-Claude
    Martin, Camille
    ACS OMEGA, 2020, 5 (03): : 1557 - 1565
  • [37] Antibody-Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors
    Mcnamara, Blair
    Greenman, Michelle
    Pebley, Nicole
    Mutlu, Levent
    Santin, Alessandro D.
    MOLECULES, 2023, 28 (21):
  • [38] Antibody-drug conjugates: can the payload improve activity in HER2 expressing cancers?
    Shah, Manish A.
    LANCET ONCOLOGY, 2017, 18 (11): : 1433 - 1434
  • [39] Monoclonal Antibodies, Small Molecule Inhibitors and Antibody-drug Conjugates as HER2 Inhibitors
    Li, Xiu-Fang
    Liu, Chen-Fu
    Rao, Guo-Wu
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (17) : 3339 - 3360
  • [40] HER2-targeted antibody-drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia
    Rainone, Michael
    Behrendt, Carolyn E.
    Kasparian, Saro
    Nguyen, Tina
    Sedrak, Mina S.
    Lavasani, Sayeh
    Stewart, Daphne B.
    Yuan, Yuan
    Mortimer, Joanne E.
    Waisman, James R.
    Patel, Niki
    Pullarkat, Vinod
    BREAST CANCER, 2023, 30 (05) : 796 - 801